Temedica GmbH

DGAP-News: Temedica announces cooperation with Bristol Myers Squibb for the development of a digital companion for psoriasis patients

Retrieved on: 
Tuesday, March 15, 2022
People, Psoriasis, Bristol Myers Squibb, Quality of life, Technology, Health, Patient, Obesity, Cardiovascular disease, Science, Diabetes, Inflammatory bowel disease, Metabolic syndrome, BioNTech, Physician, HIV disease progression rates, Prescription, United, Disease, Pharmaceutical industry, Medical device, Psoriasis, Temedica GmbH, PSORIASIS, TEMEDICA GMBH

Munich, Germany, March 15, 2022 - Temedica GmbH, a leading digital health and health insights company, today announced its cooperation with Bristol Myers Squibb to develop a digital companion for patients with psoriasis.

Key Points: 
  • Munich, Germany, March 15, 2022 - Temedica GmbH, a leading digital health and health insights company, today announced its cooperation with Bristol Myers Squibb to develop a digital companion for patients with psoriasis.
  • Psoriasis affects each patient differently, so we integrate the advice of patients as well as healthcare professionals in designing a digital companion that meets the patients' needs.
  • Dr. Michael May, Medical Director at Bristol Myers Squibb, Germany, said:
    "We are happy to support the development of an innovative digital patient companion.
  • The digital companion will enable psoriasis patients to gain a better understanding of their individual disease course and potential influencing factors.

DGAP-News: Temedica partners with NOVENTI to enhance Permea-generated insights to improve patient care

Retrieved on: 
Tuesday, February 1, 2022
BioNTech, Patient, Health care, Software, Health, HIV disease progression rates, GDPR, Physician, EHR, Intelligence, Research, ERP, Partnership, Sustainable development, Health information exchange, General Data Protection Regulation, Geography, Knowledge, FSA, Time, Board of directors, Industry, Pharmacy, Solution, Medicine, Medical device, NOVENTI, Permea, Temedica GmbH, NOVENTI, PERMEA, TEMEDICA GMBH

Temedica and NOVENTI will combine their expertise and capabilities to develop new healthcare insights through Temedica's data analytics platform, Permea.

Key Points: 
  • Temedica and NOVENTI will combine their expertise and capabilities to develop new healthcare insights through Temedica's data analytics platform, Permea.
  • NOVENTI will add specific health information to further enrich Permea's insights into patient care.
  • Temedica is a Munich, Germany-based digital health and health insights company with the mission to bring the patient into the center of healthcare.
  • Its data analytics platform Permea is designed to enable unique insights along the entire healthcare value chain and patient journey.

DGAP-News: Temedica Introduces Permea: First Analytics Platform Integrating Patient-Generated Health Data

Retrieved on: 
Wednesday, January 19, 2022
Patient, Research, Technology, Clinical trial, Algorithm, Knowledge, HIV disease progression rates, BioNTech, Intelligence, Time, Industry, Machine learning, General Data Protection Regulation, USD, Statistics, Geography, Decision-making, Anomaly, Physician, GDPR, Medical device, Pharmaceutical industry, Medical imaging, Permea, Temedica GmbH, PERMEA, TEMEDICA GMBH

Unique real-world data platform integrating proprietary, regulatory-grade, patient-generated health data

Key Points: 
  • Unique real-world data platform integrating proprietary, regulatory-grade, patient-generated health data
    Permea addresses USD 57 billion real-world evidence market potential with two new collaboration models: Permea Insights and Permea Monitor
    Munich, Germany, January 18, 2022 - Temedica GmbH, a leading digital health and data analytics company, today announces the launch of Permea.
  • The platform combines, structures, and analyzes data from multiple sources, including proprietary longitudinal patient-generated data from digital health apps and wearables, scientific publications, and prescription data.
  • Temedica has an expertise in the personalized support of patients as well as in compiling, structuring and analyzing respective health data.
  • Its data analytics platform Permea is designed to enable unique insights along the entire healthcare value chain and patient journey.